IMPACT OF INHIBITION OF KRAS/STK11-INDUCED IMMUNE SUPPRESSION IN ENHANCING IMMUNOTHERAPY RESPONSE

H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc.

Investigators